-
1
-
-
0034468489
-
Volumetric measurement of renal cysts and parenchyma using MRI: Phantoms and patients with polycystic kidney disease
-
K.T. Bae, P.K. Commean, J. Lee Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease J Comput Assist Tomogr 24 2000 614
-
(2000)
J Comput Assist Tomogr
, vol.24
, pp. 614
-
-
Bae, K.T.1
Commean, P.K.2
Lee, J.3
-
2
-
-
12444274302
-
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort
-
A.B. Chapman, L.M. Guay-Woodford, J.J. Grantham Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort Kidney Int 64 2003 1035
-
(2003)
Kidney Int
, vol.64
, pp. 1035
-
-
Chapman, A.B.1
Guay-Woodford, L.M.2
Grantham, J.J.3
-
3
-
-
33646678189
-
Volume progression in polycystic kidney disease
-
CRISP Investigators
-
J.J. Grantham, V.E. Torres, A.B. Chapman CRISP Investigators Volume progression in polycystic kidney disease N Engl J Med 354 2006 2122
-
(2006)
N Engl J Med
, vol.354
, pp. 2122
-
-
Grantham, J.J.1
Torres, V.E.2
Chapman, A.B.3
-
4
-
-
18744380752
-
Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease
-
Y. Tao, J. Kim, R.W. Schrier Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease J Am Soc Nephrol 16 2005 46
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 46
-
-
Tao, Y.1
Kim, J.2
Schrier, R.W.3
-
5
-
-
33644859253
-
Inhibition of mTOR with sirolimus slows disease progression in Han: SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)
-
P.R. Wahl, A.L. Serra, M. Le Hir Inhibition of mTOR with sirolimus slows disease progression in Han: SPRD rats with autosomal dominant polycystic kidney disease (ADPKD) Nephrol Dial Transplant 3 2006 598
-
(2006)
Nephrol Dial Transplant
, vol.3
, pp. 598
-
-
Wahl, P.R.1
Serra, A.L.2
Le Hir, M.3
-
6
-
-
71749087934
-
Sirolimus therapy for patients with adult polycystic kidney disease: A pilot study
-
A.R. Soliman, E. Ismail, S. Zamil Sirolimus therapy for patients with adult polycystic kidney disease: a pilot study Transplant Proc 41 2009 3639
-
(2009)
Transplant Proc
, vol.41
, pp. 3639
-
-
Soliman, A.R.1
Ismail, E.2
Zamil, S.3
-
7
-
-
84860633618
-
Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease
-
Z. Novalic, A.M. van der Wal, W.N. Leonhard Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease J Am Soc Nephrol 23 2012 842
-
(2012)
J Am Soc Nephrol
, vol.23
, pp. 842
-
-
Novalic, Z.1
Van Der Wal, A.M.2
Leonhard, W.N.3
-
8
-
-
35748948350
-
Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study
-
A.L. Serra, A.D. Kistler, D. Poster Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study BMC Nephrol 8 2007 13
-
(2007)
BMC Nephrol
, vol.8
, pp. 13
-
-
Serra, A.L.1
Kistler, A.D.2
Poster, D.3
-
9
-
-
40449138290
-
Sirolimus reduces polycystic liver volume in ADPKD patients
-
Q. Qian, H. Du, B.F. King Sirolimus reduces polycystic liver volume in ADPKD patients J Am Soc Nephrol 19 2008 631
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 631
-
-
Qian, Q.1
Du, H.2
King, B.F.3
-
10
-
-
84863937859
-
Invited review - Mammalian target of rapamycin and the kidney part II: Pathophysiology and therapeutic implications
-
W. Lieberthal, J.S. Levine Invited review - mammalian target of rapamycin and the kidney part II: pathophysiology and therapeutic implications Am J Physiol Renal Physiol 300 2012 180
-
(2012)
Am J Physiol Renal Physiol
, vol.300
, pp. 180
-
-
Lieberthal, W.1
Levine, J.S.2
-
11
-
-
77956029702
-
Sirolimus and kidney growth in autosomal dominant polycystic kidney disease
-
A.L. Serra, D. Poster, A.D. Kistler Sirolimus and kidney growth in autosomal dominant polycystic kidney disease N Engl J Med 363 2010 820
-
(2010)
N Engl J Med
, vol.363
, pp. 820
-
-
Serra, A.L.1
Poster, D.2
Kistler, A.D.3
-
12
-
-
77956035166
-
Everolimus in patients with autosomal dominant polycystic kidney disease
-
G. Walz, K. Budde, M. Mannaa Everolimus in patients with autosomal dominant polycystic kidney disease N Engl J Med 363 2010 830
-
(2010)
N Engl J Med
, vol.363
, pp. 830
-
-
Walz, G.1
Budde, K.2
Mannaa, M.3
-
13
-
-
77954770878
-
Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases
-
V.E. Torres, A. Boletta, A. Chapman Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases Clin J Am Soc Nephrol 5 2010 1312
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, pp. 1312
-
-
Torres, V.E.1
Boletta, A.2
Chapman, A.3
-
14
-
-
58149171924
-
Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months
-
A.D. Kistler, D. Poster, F. Krauer Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months Kidney Int 75 2009 235
-
(2009)
Kidney Int
, vol.75
, pp. 235
-
-
Kistler, A.D.1
Poster, D.2
Krauer, F.3
-
15
-
-
77956048123
-
MTOR inhibitors in polycystic kidney disease
-
T. Watnick, G. Germino mTOR inhibitors in polycystic kidney disease N Engl J Med 363 2010 879
-
(2010)
N Engl J Med
, vol.363
, pp. 879
-
-
Watnick, T.1
Germino, G.2
-
16
-
-
59649126728
-
Sirolimus CONVERT Trial Study Group Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial
-
F.P. Schena, M.D. Pascoe, J. Alberu Sirolimus CONVERT Trial Study Group Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial Transplantation 87 2009 233
-
(2009)
Transplantation
, vol.87
, pp. 233
-
-
Schena, F.P.1
Pascoe, M.D.2
Alberu, J.3
-
17
-
-
78649503269
-
Autosomal dominant polycystic kidney disease and mTOR inhibitors: The narrow road between hope and disappointment
-
C. Ponticelli, F. Locatelli Autosomal dominant polycystic kidney disease and mTOR inhibitors: the narrow road between hope and disappointment Nephrol Dial Transplant 25 2010 3809
-
(2010)
Nephrol Dial Transplant
, vol.25
, pp. 3809
-
-
Ponticelli, C.1
Locatelli, F.2
|